Theranostics,
Journal Year:
2024,
Volume and Issue:
14(15), P. 5945 - 5964
Published: Jan. 1, 2024
Bacteria-mediated
tumor
therapy
has
showed
promising
potential
for
cancer
therapy.
However,
the
efficacy
of
bacterial
monotherapy
treatment
which
can
express
and
release
therapeutic
proteins
in
tumors
been
found
to
be
unsatisfactory.
To
date,
synergistic
emerged
as
a
approach
achieve
stronger
outcomes
compared
monotherapy.
It
is
challenge
visualize
these
tumor-homing
bacteria
Biomedical Physics & Engineering Express,
Journal Year:
2024,
Volume and Issue:
10(5), P. 052002 - 052002
Published: Aug. 14, 2024
Abstract
Purpose
.
This
review
aims
to
highlight
current
improvements
in
microfluidic
devices
designed
for
digestive
cancer
simulation.
The
emphasizes
the
use
of
multicellular
3D
tissue
engineering
models
understand
complicated
biology
tumor
microenvironment
(TME)
and
progression.
purpose
is
develop
oncology
research
improve
patients’
lives.
Methods
analyzes
recent
on
mimicking
cancer.
It
uses
tissue-engineered
devices,
notably
organs
a
chip
(OOC),
simulate
human
organ
function
lab.
Cell
cultivation
modern
three-dimensional
hydrogel
platforms
allows
precise
geometry,
biological
components,
physiological
qualities.
novel
methodologies,
key
findings,
technical
progress
explain
this
field’s
advances.
Results
study
discusses
advances
Micro
systems
with
are
emphasized.
These
capture
complex
biochemical
gradients,
niche
variables,
dynamic
cell–cell
interactions
(TME).
reveal
stomach
progression
by
duplicating
TME.
Recent
discoveries
technology
have
improved
our
understanding
gut
biology,
as
shown
review.
Conclusion
Microfluidic
play
crucial
role
modeling
furthering
research.
could
transform
drug
development
treatment
revealing
provides
complete
summary
suggests
future
field
professionals.
review’s
major
goal
further
medical
Polymers for Advanced Technologies,
Journal Year:
2024,
Volume and Issue:
35(10)
Published: Oct. 1, 2024
ABSTRACT
Nanogels
represent
a
significant
innovation
in
the
fields
of
nanotechnology
and
biomedical
engineering,
combining
properties
hydrogels
nanoparticles
to
create
versatile
platforms
for
drug
delivery,
tissue
bioimaging,
other
applications.
These
nanoscale
hydrogels,
typically
ranging
from
10
1000
nm,
possess
unique
characteristics
such
as
high
water
content,
biocompatibility,
ability
encapsulate
both
hydrophilic
hydrophobic
molecules.
The
review
explores
synthesis,
structural
configurations,
stimuli‐responsive
nature
nanogels,
highlighting
their
adaptability
targeted
including
across
challenging
barriers
like
blood–brain
barrier.
Furthermore,
paper
delves
into
applications
particularly
delivery
systems,
demonstrating
potential
revolutionize
these
fields.
Despite
promising
preclinical
results,
challenges
remain
translating
technologies
clinical
practice,
issues
related
stability,
scalability,
regulatory
approval.
concludes
by
discussing
future
perspectives,
emphasizing
need
further
research
optimize
ultimately
aiming
enhance
efficacy
safety
settings.
Applied Biochemistry and Biotechnology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 5, 2025
Abstract
Endophytic
fungi
represent
a
significant
renewable
resource
for
the
discovery
of
pharmaceutically
important
compounds,
offering
substantial
potential
new
drug
development.
Their
ability
to
address
growing
issue
resistance
has
drawn
attention
from
researchers
seeking
novel,
nature-derived
lead
molecules
that
can
be
produced
on
large
scale
meet
global
demand.
Recent
advancements
in
genomics,
metabolomics,
bioinformatics,
and
improved
cultivation
techniques
have
significantly
aided
identification
characterization
fungal
endophytes
their
metabolites.
Current
estimates
suggest
there
are
approximately
1.20
million
globally,
yet
only
around
16%
(190,000)
been
identified
studied
detail.
This
underscores
vast
untapped
pharmaceutical
research.
Research
increasingly
focused
transformation
bioactive
compounds
by
through
chemical
enzymatic
processes.
A
notable
example
is
anthraquinone
derivative
6-O-methylalaternin,
whose
cytotoxic
enhanced
addition
hydroxyl
group,
sharing
structural
similarities
with
its
parent
compound
macrosporin.
These
structure-bioactivity
studies
open
up
avenues
developing
safer
more
effective
therapeutic
agents
synthesizing
targeted
derivatives.
Despite
immense
promise,
challenges
remain,
particularly
large-scale
understanding
complexities
biosynthetic
pathways.
Additionally,
genetic
manipulation
optimized
metabolite
production
still
infancy.
Future
research
should
aim
overcome
these
limitations
focusing
efficient
methods
deeper
exploration
endophytes’
metabolic
capabilities
fully
harness
potential.
Graphical
Biotechnology and Applied Biochemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 21, 2025
ABSTRACT
As
a
significant
cause
of
global
mortality,
the
cancer
has
also
economic
impacts.
In
era
therapy,
mitigating
side
effects
and
costs
overcoming
drug
resistance
is
crucial.
Microbial
species
can
grow
inside
tumor
microenvironment
inhibit
growth
through
direct
killing
cells
immunoregulatory
effects.
Although
microbiota
or
their
products
have
demonstrated
anticancer
effects,
possibility
acting
as
pathogens
exerting
in
certain
individuals
risk.
Hence,
several
genetically
modified/engineered
bacteria
(GEB)
been
developed
to
this
aim
with
ability
diagnosing
selective
targeting
destruction
cancers.
Additionally,
GEB
are
expected
be
considerably
more
efficient,
safer,
permeable,
less
costly,
invasive
theranostic
approaches
compared
wild
types.
Potential
strains
such
Escherichia
coli
(Nissle
1917,
MG1655),
Salmonella
typhimurium
YB1
SL7207
(
aroA
gene
deletion),
VNP20009
(∆msbB/∆purI)
ΔppGpp
(P
Tet
P
BAD
),
Listeria
monocytogenes
Lm
at
‐LLO
combat
cells.
When
used
tandem
conventional
treatments,
substantially
improve
efficacy
therapy
outcomes.
addition,
public
acceptance,
optimal
timing
(s),
duration
dose
identification,
interactions
other
host
cells,
efficacy,
safety
quality,
potential
risks
ethical
dilemmas
include
major
challenges.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(38)
Published: July 26, 2024
Abstract
In
recent
years,
advancements
in
microbial
sequencing
technology
have
sparked
an
increasing
interest
the
bacteria
residing
within
solid
tumors
and
its
distribution
functions
various
tumors.
Intratumoral
critically
modulate
tumor
oncogenesis
development
through
DNA
damage
induction,
chronic
inflammation,
epigenetic
alterations,
metabolic
immune
regulation,
while
also
influencing
cancer
treatment
efficacy
by
affecting
drug
metabolism.
response
to
these
discoveries,
a
variety
of
anti‐cancer
therapies
targeting
microorganisms
emerged.
These
approaches
encompass
oncolytic
therapy
utilizing
tumor‐associated
bacteria,
design
biomaterials
based
on
intratumoral
use
bacterial
components
for
delivery
systems,
comprehensive
strategies
aimed
at
eradication
tumor‐promoting
bacteria.
Herein,
this
review
article
summarizes
patterns
different
tumors,
examines
their
impact
evaluates
current
therapeutic
centered
Furthermore,
challenges
prospects
developing
drugs
that
target
communities
are
explored,
promising
new
directions
treatment.